Which companies does Genmab have alliances with?
To maximize the value of our integrated human antibody development capabilities, Genmab is forming numerous partnerships with other biotechnology and pharmaceutical companies to co-develop antibody products to novel disease targets. Our partners range from small privately held companies to major pharmaceutical and biotech companies such as Roche, Amgen and GlaxoSmithKline. A broad alliance provides Genmab with access to Medarex, Inc.’s array of proprietary technologies including the UltiMAb® platform for the rapid creation and development of human antibodies to virtually any disease target.
